Pfizer to buy back plant and then sell or shutter; Cold chain breaks are culprit in child vax deaths;

> Pfizer will buy back a manufacturing facility in Rouses Point, NY, from current owner Akrimax Pharmaceuticals and will either sell or shutter it by 2013. News

> Cold chain breakdowns between production to the last mile are the leading culprit in the increased death rate of Indian children after immunization. Story

> The FDA has reportedly inspected the manufacturing plants of at least six Indian drugmakers, raising their hopes of exporting medicines to the U.S. Article

> Despite calling them "serious offenses," a judge has sentenced Graham Dawson to two years of community service and 100 hours of unpaid work for supplying fake Viagra from China to customers in the U.K. News

> Following the lead of governments and regulators around the world, India has pushed back the deadline for a track and trace initiative, this one based on barcode technology for export consignments of drugs. Story

> Bausch & Lomb will launch a pharmaceutical business in India through a strategic collaboration with Micro Labs, a Indian drug manufacturing organization. Report

> Mumbai-based hard capsule manufacturer ACG Worldwide plans to invest $135 million over three years to expand manufacturing capacity. Item

> OctoPlus says it has signed a process development and manufacturing contract a pharmaceutical company headquartered in Denmark. Item